Protara Therapeutics Named a 2026 Best Places to Work Winner by BioSpace

Core Insights - Protara Therapeutics, Inc. has been recognized as one of the Best Places to Work by BioSpace for 2026, highlighting its status as a desirable employer in the biotech sector [1][2] - The company is particularly noted for its commitment to fostering a vibrant workplace culture that attracts top talent and inspires employees [2][3] Company Overview - Protara Therapeutics is a clinical-stage biotechnology company focused on developing transformative therapies for cancer and rare diseases [4] - The company's lead candidate, TARA-002, is an investigational cell-based therapy aimed at treating non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs) [4] - Protara is currently conducting a Phase 2 trial for TARA-002 in NMIBC patients who are unresponsive or naïve to Bacillus Calmette-Guérin (BCG) treatment, as well as a Phase 2 trial in pediatric patients with LMs [4] - Additionally, the company is developing IV Choline Chloride, a phospholipid substrate replacement for patients on parenteral nutrition [4] Workplace Environment - Protara is located in the Flatiron District of New York City and emphasizes a modern, collaborative working environment that values integrity, tenacity, and teamwork [3] - The company offers competitive benefits and prioritizes professional development, inclusivity, and work-life balance [3] - The Best Places to Work nominations were based on votes from over 7,500 life sciences professionals, who evaluated companies on various attributes including compensation, innovation, and culture [3]